Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-05

AUTHORS

Takamasa Ohki, Mayuko Kondo, Yuki Karasawa, Satoshi Kawamura, Shuuya Maeshima, Kentaro Kojima, Michiharu Seki, Nobuo Toda, Yoshinobu Shioda, Kazumi Tagawa

ABSTRACT

INTRODUCTION: Transcatheter arterial chemoembolization (TACE) is the first-line treatment for intermediate stage hepatocellular carcinoma (HCC) and prolongs survival in HCC patients. However, repeated TACE results in diminished therapeutic response. In addition, the superiority of sorafenib to TACE monotherapy or combined therapy in patients with HCC is still controversial. The prognosis of HCC has many variables and, thus, the effect of a specific treatment is difficult to evaluate. The frequency of treatments per year (FT rate) used in this study was obtained by dividing the total number of radiofrequency ablations and TACE or transcatheter arterial infusion treatments by the years of survival. The aim of this study was to evaluate the overall survival (OS) of TACE versus sorafenib using the FT rate. METHODS: We compared the OS of patients with recurrence of HCC receiving repeated TACE monotherapy (CON) with those receiving therapy switched from TACE to sorafenib (SOR). In addition, a one-to-one FT rate matching cohort consisting of matched SOR (mSOR) and matched CON (mCON) was determined using the propensity score matching method, and OS in the cohort was evaluated. Factors influencing survival were evaluated using Cox proportional hazard regression analysis in all patients and the FT rate matched cohort. RESULTS: In the FT rate matched cohort, the cumulative survival rate was significantly higher in the mSOR group compared with the mCON group. Multivariate regression analysis of the FT rate matched cohort showed the FT rate and sorafenib to be significant variables for survival with a hazard ratio (HR) of 2.86 (p < 0.001) and 0.42 (p = 0.008), respectively. CONCLUSION: Early switching from TACE to sorafenib therapy may prolong OS in HCC patients unresponsive to TACE. The present study indicates that the FT rate is potentially a useful index in evaluating the outcome for patients at various stages and treatment regimens. FUNDING: Bayer Yakuhin, Ltd. More... »

PAGES

1097-1108

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12325-017-0524-9

DOI

http://dx.doi.org/10.1007/s12325-017-0524-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1084520132

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28389996


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemoembolization, Therapeutic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Niacinamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenylurea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sorafenib", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Mitsui Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415980.1", 
          "name": [
            "Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohki", 
        "givenName": "Takamasa", 
        "id": "sg:person.0735132461.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735132461.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mitsui Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415980.1", 
          "name": [
            "Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kondo", 
        "givenName": "Mayuko", 
        "id": "sg:person.014564007503.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014564007503.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mitsui Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415980.1", 
          "name": [
            "Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karasawa", 
        "givenName": "Yuki", 
        "id": "sg:person.010757622255.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010757622255.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mitsui Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415980.1", 
          "name": [
            "Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawamura", 
        "givenName": "Satoshi", 
        "id": "sg:person.014510376031.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014510376031.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mitsui Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415980.1", 
          "name": [
            "Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maeshima", 
        "givenName": "Shuuya", 
        "id": "sg:person.07453677303.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07453677303.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mitsui Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415980.1", 
          "name": [
            "Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kojima", 
        "givenName": "Kentaro", 
        "id": "sg:person.0575367145.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575367145.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mitsui Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415980.1", 
          "name": [
            "Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seki", 
        "givenName": "Michiharu", 
        "id": "sg:person.0643502345.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643502345.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mitsui Memorial Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415980.1", 
          "name": [
            "Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Toda", 
        "givenName": "Nobuo", 
        "id": "sg:person.01072014047.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072014047.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Surgery, Shioda Hospital, Katsuura City, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shioda", 
        "givenName": "Yoshinobu", 
        "id": "sg:person.012441601303.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012441601303.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Surgery, Shioda Hospital, Katsuura City, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tagawa", 
        "givenName": "Kazumi", 
        "id": "sg:person.01141347054.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141347054.93"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ejca.2011.05.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000573856"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/jhep.2002.33156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002281277"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00432-014-1684-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012677147", 
          "https://doi.org/10.1007/s00432-014-1684-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-04-1443", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014291431"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40261-015-0333-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018123793", 
          "https://doi.org/10.1007/s40261-015-0333-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40261-015-0333-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018123793", 
          "https://doi.org/10.1007/s40261-015-0333-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(08)70285-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018829845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11033-014-3541-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021344390", 
          "https://doi.org/10.1007/s11033-014-3541-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/1751-2980.12038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023275766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000365993", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027201561"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0100305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027991110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-015-1129-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028025494", 
          "https://doi.org/10.1007/s00535-015-1129-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40261-015-0363-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028167206", 
          "https://doi.org/10.1007/s40261-015-0363-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0091124", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030366085"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0030-1247132", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031319462"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jhep.2016.01.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037879842"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mcg.0000000000000144", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042329504"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mcg.0000000000000144", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042329504"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000327577", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046800793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(02)08649-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051479393"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000367743", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052358491"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinre.2016.04.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053506933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0708857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053513212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0034-1394143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057327956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3748/wjg.v10.i19.2878", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071362516"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3748/wjg.v11.i23.3644", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071363268"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3748/wjg.v20.i39.14381", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071371643"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/etm.2011.237", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071502971"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079217441", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.15075", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083547338"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-05", 
    "datePublishedReg": "2017-05-01", 
    "description": "INTRODUCTION: Transcatheter arterial chemoembolization (TACE) is the first-line treatment for intermediate stage hepatocellular carcinoma (HCC) and prolongs survival in HCC patients. However, repeated TACE results in diminished therapeutic response. In addition, the superiority of sorafenib to TACE monotherapy or combined therapy in patients with HCC is still controversial. The prognosis of HCC has many variables and, thus, the effect of a specific treatment is difficult to evaluate. The frequency of treatments per year (FT rate) used in this study was obtained by dividing the total number of radiofrequency ablations and TACE or transcatheter arterial infusion treatments by the years of survival. The aim of this study was to evaluate the overall survival (OS) of TACE versus sorafenib using the FT rate.\nMETHODS: We compared the OS of patients with recurrence of HCC receiving repeated TACE monotherapy (CON) with those receiving therapy switched from TACE to sorafenib (SOR). In addition, a one-to-one FT rate matching cohort consisting of matched SOR (mSOR) and matched CON (mCON) was determined using the propensity score matching method, and OS in the cohort was evaluated. Factors influencing survival were evaluated using Cox proportional hazard regression analysis in all patients and the FT rate matched cohort.\nRESULTS: In the FT rate matched cohort, the cumulative survival rate was significantly higher in the mSOR group compared with the mCON group. Multivariate regression analysis of the FT rate matched cohort showed the FT rate and sorafenib to be significant variables for survival with a hazard ratio (HR) of 2.86 (p\u00a0<\u00a00.001) and 0.42 (p\u00a0=\u00a00.008), respectively.\nCONCLUSION: Early switching from TACE to sorafenib therapy may prolong OS in HCC patients unresponsive to TACE. The present study indicates that the FT rate is potentially a useful index in evaluating the outcome for patients at various stages and treatment regimens.\nFUNDING: Bayer Yakuhin, Ltd.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12325-017-0524-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1096634", 
        "issn": [
          "0741-238X", 
          "1865-8652"
        ], 
        "name": "Advances in Therapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "34"
      }
    ], 
    "name": "Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index", 
    "pagination": "1097-1108", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "392b939d930dc4854d76227c93247c6d5a1167faac47b264b34763eb070fde90"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28389996"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8611864"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12325-017-0524-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1084520132"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12325-017-0524-9", 
      "https://app.dimensions.ai/details/publication/pub.1084520132"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89790_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs12325-017-0524-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12325-017-0524-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12325-017-0524-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12325-017-0524-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12325-017-0524-9'


 

This table displays all metadata directly associated to this object as RDF triples.

296 TRIPLES      21 PREDICATES      75 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12325-017-0524-9 schema:about N05ca3f777e014204b649356219cf534b
2 N1530e5ff70914edb9308f8c040d835e5
3 N1c8703418901444a8227ed4bc79db536
4 N2ca7a7fd662d4cb58ebd29934653ee50
5 N4668f3f0ab8345e194403e8c84350c4e
6 N55ac7e612992498a88387778f244c81c
7 N60d6959cfb914d80abd296f1cf6005c8
8 N685a3b32754a491dba6a586282af1975
9 N7587cd6bd62e448db009d3e6496a7eb2
10 N8864a321626d48bbb1aab20fb5cc6f00
11 N8a5b7a52b0694da081d70d4013b3c629
12 N9c83bd2cf1244f1db7107a3ee64e60cb
13 Na0ede0c49ff5473aaf856a7e3e5317f5
14 Na84d9a1b32b748b891bb696fbd0ad613
15 Ncb8906f3069e4886b4dc96dbe9169ac0
16 Nd530d8675e474532ae5ab693a73e91c0
17 Neade001634e841a98f4f8c3baa2f6442
18 Neaee5f312225498e80f52cb4c9b2868f
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author N907373cae72542979379e1e023405b19
22 schema:citation sg:pub.10.1007/s00432-014-1684-5
23 sg:pub.10.1007/s00535-015-1129-1
24 sg:pub.10.1007/s11033-014-3541-7
25 sg:pub.10.1007/s40261-015-0333-3
26 sg:pub.10.1007/s40261-015-0363-x
27 https://app.dimensions.ai/details/publication/pub.1079217441
28 https://doi.org/10.1016/j.clinre.2016.04.006
29 https://doi.org/10.1016/j.ejca.2011.05.007
30 https://doi.org/10.1016/j.jhep.2016.01.012
31 https://doi.org/10.1016/s0140-6736(02)08649-x
32 https://doi.org/10.1016/s1470-2045(08)70285-7
33 https://doi.org/10.1053/jhep.2002.33156
34 https://doi.org/10.1055/s-0030-1247132
35 https://doi.org/10.1055/s-0034-1394143
36 https://doi.org/10.1056/nejmoa0708857
37 https://doi.org/10.1097/mcg.0000000000000144
38 https://doi.org/10.1111/1751-2980.12038
39 https://doi.org/10.1158/0008-5472.can-04-1443
40 https://doi.org/10.1159/000327577
41 https://doi.org/10.1159/000365993
42 https://doi.org/10.1159/000367743
43 https://doi.org/10.1371/journal.pone.0091124
44 https://doi.org/10.1371/journal.pone.0100305
45 https://doi.org/10.18632/oncotarget.15075
46 https://doi.org/10.3748/wjg.v10.i19.2878
47 https://doi.org/10.3748/wjg.v11.i23.3644
48 https://doi.org/10.3748/wjg.v20.i39.14381
49 https://doi.org/10.3892/etm.2011.237
50 schema:datePublished 2017-05
51 schema:datePublishedReg 2017-05-01
52 schema:description INTRODUCTION: Transcatheter arterial chemoembolization (TACE) is the first-line treatment for intermediate stage hepatocellular carcinoma (HCC) and prolongs survival in HCC patients. However, repeated TACE results in diminished therapeutic response. In addition, the superiority of sorafenib to TACE monotherapy or combined therapy in patients with HCC is still controversial. The prognosis of HCC has many variables and, thus, the effect of a specific treatment is difficult to evaluate. The frequency of treatments per year (FT rate) used in this study was obtained by dividing the total number of radiofrequency ablations and TACE or transcatheter arterial infusion treatments by the years of survival. The aim of this study was to evaluate the overall survival (OS) of TACE versus sorafenib using the FT rate. METHODS: We compared the OS of patients with recurrence of HCC receiving repeated TACE monotherapy (CON) with those receiving therapy switched from TACE to sorafenib (SOR). In addition, a one-to-one FT rate matching cohort consisting of matched SOR (mSOR) and matched CON (mCON) was determined using the propensity score matching method, and OS in the cohort was evaluated. Factors influencing survival were evaluated using Cox proportional hazard regression analysis in all patients and the FT rate matched cohort. RESULTS: In the FT rate matched cohort, the cumulative survival rate was significantly higher in the mSOR group compared with the mCON group. Multivariate regression analysis of the FT rate matched cohort showed the FT rate and sorafenib to be significant variables for survival with a hazard ratio (HR) of 2.86 (p < 0.001) and 0.42 (p = 0.008), respectively. CONCLUSION: Early switching from TACE to sorafenib therapy may prolong OS in HCC patients unresponsive to TACE. The present study indicates that the FT rate is potentially a useful index in evaluating the outcome for patients at various stages and treatment regimens. FUNDING: Bayer Yakuhin, Ltd.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree true
56 schema:isPartOf N2620bea6ddd047608a12b35ff6738376
57 N848b298572fa471889b810999bac8638
58 sg:journal.1096634
59 schema:name Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index
60 schema:pagination 1097-1108
61 schema:productId N41a29f8b21794e569f9ae696f358ee39
62 N7ab703aa59cb49639a791c577ab37a01
63 Ne722855f931845da9ef5ffca5305cf7c
64 Nedaff6cfbaa54a028897953c4e76e508
65 Nfddcff4dd0da43fea49530b35d6e923d
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084520132
67 https://doi.org/10.1007/s12325-017-0524-9
68 schema:sdDatePublished 2019-04-11T09:52
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher N5b6b4a91eea14de8b6e3a37eec0d5fae
71 schema:url https://link.springer.com/10.1007%2Fs12325-017-0524-9
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N05ca3f777e014204b649356219cf534b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Antineoplastic Agents
77 rdf:type schema:DefinedTerm
78 N14328ad7dd994011b88dab768e27eeba rdf:first sg:person.01072014047.79
79 rdf:rest N623d017534544e8f86af092ac5b1e1bb
80 N1530e5ff70914edb9308f8c040d835e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Chemoembolization, Therapeutic
82 rdf:type schema:DefinedTerm
83 N19c6afd4f79d4ab688a08ad508a548fa rdf:first sg:person.014510376031.49
84 rdf:rest N677ba67c8531443d87efc9124d5a7aea
85 N1c8703418901444a8227ed4bc79db536 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Liver Neoplasms
87 rdf:type schema:DefinedTerm
88 N24cd716e47b84c3eaf120adaaf85a285 rdf:first sg:person.0643502345.12
89 rdf:rest N14328ad7dd994011b88dab768e27eeba
90 N2620bea6ddd047608a12b35ff6738376 schema:issueNumber 5
91 rdf:type schema:PublicationIssue
92 N2ca7a7fd662d4cb58ebd29934653ee50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Niacinamide
94 rdf:type schema:DefinedTerm
95 N41a29f8b21794e569f9ae696f358ee39 schema:name doi
96 schema:value 10.1007/s12325-017-0524-9
97 rdf:type schema:PropertyValue
98 N4668f3f0ab8345e194403e8c84350c4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Carcinoma, Hepatocellular
100 rdf:type schema:DefinedTerm
101 N46e774394ae748dca38d15ed8a9c9851 rdf:first sg:person.010757622255.62
102 rdf:rest N19c6afd4f79d4ab688a08ad508a548fa
103 N55ac7e612992498a88387778f244c81c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Cohort Studies
105 rdf:type schema:DefinedTerm
106 N5810464e39664a83bafaf730f25e95c7 rdf:first sg:person.0575367145.40
107 rdf:rest N24cd716e47b84c3eaf120adaaf85a285
108 N5b6b4a91eea14de8b6e3a37eec0d5fae schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 N60d6959cfb914d80abd296f1cf6005c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Female
112 rdf:type schema:DefinedTerm
113 N623d017534544e8f86af092ac5b1e1bb rdf:first sg:person.012441601303.94
114 rdf:rest N69cbb1290d46486aa383a019971ddea2
115 N677ba67c8531443d87efc9124d5a7aea rdf:first sg:person.07453677303.59
116 rdf:rest N5810464e39664a83bafaf730f25e95c7
117 N685a3b32754a491dba6a586282af1975 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Neoplasm Recurrence, Local
119 rdf:type schema:DefinedTerm
120 N6887a0c387b6411fbdfa5e1ef1dac204 schema:name Department of Surgery, Shioda Hospital, Katsuura City, Japan
121 rdf:type schema:Organization
122 N69cbb1290d46486aa383a019971ddea2 rdf:first sg:person.01141347054.93
123 rdf:rest rdf:nil
124 N7587cd6bd62e448db009d3e6496a7eb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Adult
126 rdf:type schema:DefinedTerm
127 N760f95e765674f45a643b58e58861eb8 rdf:first sg:person.014564007503.05
128 rdf:rest N46e774394ae748dca38d15ed8a9c9851
129 N7ab703aa59cb49639a791c577ab37a01 schema:name readcube_id
130 schema:value 392b939d930dc4854d76227c93247c6d5a1167faac47b264b34763eb070fde90
131 rdf:type schema:PropertyValue
132 N848b298572fa471889b810999bac8638 schema:volumeNumber 34
133 rdf:type schema:PublicationVolume
134 N8864a321626d48bbb1aab20fb5cc6f00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Phenylurea Compounds
136 rdf:type schema:DefinedTerm
137 N8a5b7a52b0694da081d70d4013b3c629 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Survival Rate
139 rdf:type schema:DefinedTerm
140 N907373cae72542979379e1e023405b19 rdf:first sg:person.0735132461.52
141 rdf:rest N760f95e765674f45a643b58e58861eb8
142 N9c83bd2cf1244f1db7107a3ee64e60cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Treatment Outcome
144 rdf:type schema:DefinedTerm
145 Na0ede0c49ff5473aaf856a7e3e5317f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Middle Aged
147 rdf:type schema:DefinedTerm
148 Na84d9a1b32b748b891bb696fbd0ad613 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Aged, 80 and over
150 rdf:type schema:DefinedTerm
151 Ncb8906f3069e4886b4dc96dbe9169ac0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Male
153 rdf:type schema:DefinedTerm
154 Nd530d8675e474532ae5ab693a73e91c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Humans
156 rdf:type schema:DefinedTerm
157 Ne722855f931845da9ef5ffca5305cf7c schema:name pubmed_id
158 schema:value 28389996
159 rdf:type schema:PropertyValue
160 Neade001634e841a98f4f8c3baa2f6442 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Sorafenib
162 rdf:type schema:DefinedTerm
163 Neaee5f312225498e80f52cb4c9b2868f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Aged
165 rdf:type schema:DefinedTerm
166 Nec43bf2c7d2249d68d82b6fdd126dda1 schema:name Department of Surgery, Shioda Hospital, Katsuura City, Japan
167 rdf:type schema:Organization
168 Nedaff6cfbaa54a028897953c4e76e508 schema:name nlm_unique_id
169 schema:value 8611864
170 rdf:type schema:PropertyValue
171 Nfddcff4dd0da43fea49530b35d6e923d schema:name dimensions_id
172 schema:value pub.1084520132
173 rdf:type schema:PropertyValue
174 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
175 schema:name Medical and Health Sciences
176 rdf:type schema:DefinedTerm
177 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
178 schema:name Clinical Sciences
179 rdf:type schema:DefinedTerm
180 sg:journal.1096634 schema:issn 0741-238X
181 1865-8652
182 schema:name Advances in Therapy
183 rdf:type schema:Periodical
184 sg:person.01072014047.79 schema:affiliation https://www.grid.ac/institutes/grid.415980.1
185 schema:familyName Toda
186 schema:givenName Nobuo
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072014047.79
188 rdf:type schema:Person
189 sg:person.010757622255.62 schema:affiliation https://www.grid.ac/institutes/grid.415980.1
190 schema:familyName Karasawa
191 schema:givenName Yuki
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010757622255.62
193 rdf:type schema:Person
194 sg:person.01141347054.93 schema:affiliation N6887a0c387b6411fbdfa5e1ef1dac204
195 schema:familyName Tagawa
196 schema:givenName Kazumi
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141347054.93
198 rdf:type schema:Person
199 sg:person.012441601303.94 schema:affiliation Nec43bf2c7d2249d68d82b6fdd126dda1
200 schema:familyName Shioda
201 schema:givenName Yoshinobu
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012441601303.94
203 rdf:type schema:Person
204 sg:person.014510376031.49 schema:affiliation https://www.grid.ac/institutes/grid.415980.1
205 schema:familyName Kawamura
206 schema:givenName Satoshi
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014510376031.49
208 rdf:type schema:Person
209 sg:person.014564007503.05 schema:affiliation https://www.grid.ac/institutes/grid.415980.1
210 schema:familyName Kondo
211 schema:givenName Mayuko
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014564007503.05
213 rdf:type schema:Person
214 sg:person.0575367145.40 schema:affiliation https://www.grid.ac/institutes/grid.415980.1
215 schema:familyName Kojima
216 schema:givenName Kentaro
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575367145.40
218 rdf:type schema:Person
219 sg:person.0643502345.12 schema:affiliation https://www.grid.ac/institutes/grid.415980.1
220 schema:familyName Seki
221 schema:givenName Michiharu
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643502345.12
223 rdf:type schema:Person
224 sg:person.0735132461.52 schema:affiliation https://www.grid.ac/institutes/grid.415980.1
225 schema:familyName Ohki
226 schema:givenName Takamasa
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735132461.52
228 rdf:type schema:Person
229 sg:person.07453677303.59 schema:affiliation https://www.grid.ac/institutes/grid.415980.1
230 schema:familyName Maeshima
231 schema:givenName Shuuya
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07453677303.59
233 rdf:type schema:Person
234 sg:pub.10.1007/s00432-014-1684-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012677147
235 https://doi.org/10.1007/s00432-014-1684-5
236 rdf:type schema:CreativeWork
237 sg:pub.10.1007/s00535-015-1129-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028025494
238 https://doi.org/10.1007/s00535-015-1129-1
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/s11033-014-3541-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021344390
241 https://doi.org/10.1007/s11033-014-3541-7
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/s40261-015-0333-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018123793
244 https://doi.org/10.1007/s40261-015-0333-3
245 rdf:type schema:CreativeWork
246 sg:pub.10.1007/s40261-015-0363-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028167206
247 https://doi.org/10.1007/s40261-015-0363-x
248 rdf:type schema:CreativeWork
249 https://app.dimensions.ai/details/publication/pub.1079217441 schema:CreativeWork
250 https://doi.org/10.1016/j.clinre.2016.04.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053506933
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/j.ejca.2011.05.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000573856
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1016/j.jhep.2016.01.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037879842
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1016/s0140-6736(02)08649-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051479393
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1016/s1470-2045(08)70285-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018829845
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1053/jhep.2002.33156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002281277
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1055/s-0030-1247132 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031319462
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1055/s-0034-1394143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057327956
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1056/nejmoa0708857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053513212
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1097/mcg.0000000000000144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042329504
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1111/1751-2980.12038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023275766
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1158/0008-5472.can-04-1443 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014291431
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1159/000327577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046800793
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1159/000365993 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027201561
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1159/000367743 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052358491
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1371/journal.pone.0091124 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030366085
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1371/journal.pone.0100305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027991110
283 rdf:type schema:CreativeWork
284 https://doi.org/10.18632/oncotarget.15075 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083547338
285 rdf:type schema:CreativeWork
286 https://doi.org/10.3748/wjg.v10.i19.2878 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071362516
287 rdf:type schema:CreativeWork
288 https://doi.org/10.3748/wjg.v11.i23.3644 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071363268
289 rdf:type schema:CreativeWork
290 https://doi.org/10.3748/wjg.v20.i39.14381 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071371643
291 rdf:type schema:CreativeWork
292 https://doi.org/10.3892/etm.2011.237 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071502971
293 rdf:type schema:CreativeWork
294 https://www.grid.ac/institutes/grid.415980.1 schema:alternateName Mitsui Memorial Hospital
295 schema:name Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan
296 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...